EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Coagulation Testing Practices and Guideline Adherence in Hemophilia A: A Retrospective Quality Assessment of a Dutch Expertise Hemophilia Treatment Center

A P Bavinck, W van Heerde, S R Rijpma, N Blijlevens, S E M Schols

Haemophilia · 01.11.2026

DOI: 10.1111/hae.70450 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Haemophilia, online erschienen am 01.11.2026. Verfasst von A P Bavinck und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Radboud University Medical Centre, , the Netherlands. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Enzyre BV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coagulation testing in persons with hemophilia A (PwHA) is required for diagnosis, monitoring replacement therapy, assessment of adherence, and detection of inhibitors. However, data on testing practices are limited, and alignment with guideline recommendations is unclear.

Objectives

To describe longitudinal coagulation testing practices in adult PwHA, assess guideline adherence, and explore the clinical consequences of current testing practices.

Methods

Coagulation testing of adult PwHA of all severities treated at a single Dutch hemophilia treatment center between 2014–2025 were retrospectively analyzed. Patient characteristics, coagulation assays, FVIII exposure, and interventions were pseudonymously extracted from patient records.

Results

Persons with severe (n = 31), moderate (n = 31), and mild (n = 131) hemophilia A were included. Median annual testing rate increased from 0.6 [IQR 0.3–1.0] in mild PwHA to 2.3 [IQR 1.7–3.3] in severe PwHA. The annual testing rate decreased from 1.7 [IQR 1.4–2.0] pre‐2020 to 0.7 [IQR 0.7–0.7] from 2020 onwards. Adherence was low across three guidelines (adherence 1%–38%). The most common clinical consequences of testing were emicizumab dose adjustments in 7/27 (26%) emicizumab‐treated PwHA and detection of periinterventional below‐target FVIII levels immediately post‐intervention (19/49, 37%) or within the first two postoperative days (46/136, 34%). Bleeding complications occurred in 13% of interventions with below‐target FVIII levels versus 5% with levels within target.

Conclusions

Coagulation testing rates in PwHA declined over time and guideline adherence was low. Further discussion on improved monitoring strategies and guidelines is warranted, particularly considering the major changes in hemophilia treatment over the past decade.

Schlagwörter

Stichwörter der Autor:innen

Blood coagulation testsHemophilia Aguideline adherencemonitoring

Autor:innen und Institutionen

  • Department of Hematology, Radboud University Medical Centre, , the Netherlands.
  • Enzyre, Nijmegen, the Netherlands.
  • Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, the Netherlands.
  • Laboratory of Hematology, Radboud University Medical Centre, , the Netherlands.

Förderung

  • Enzyre BV

Zitieren

APA

Bavinck, A. P., van Heerde, W., Rijpma, S. R., Blijlevens, N., & Schols, S. E. M. (2026). Coagulation Testing Practices and Guideline Adherence in Hemophilia A: A Retrospective Quality Assessment of a Dutch Expertise Hemophilia Treatment Center. Haemophilia. https://doi.org/10.1111/hae.70450

Vancouver

Bavinck AP, van Heerde W, Rijpma SR, Blijlevens N, Schols SEM. Coagulation Testing Practices and Guideline Adherence in Hemophilia A: A Retrospective Quality Assessment of a Dutch Expertise Hemophilia Treatment Center. Haemophilia. 2026. doi:10.1111/hae.70450

BibTeX
@article{Bavinck2026,
  author = {Bavinck, A P and van Heerde, W and Rijpma, S R and Blijlevens, N and Schols, S E M},
  title = {Coagulation Testing Practices and Guideline Adherence in Hemophilia A: A Retrospective Quality Assessment of a Dutch Expertise Hemophilia Treatment Center},
  journal = {Haemophilia},
  year = {2026},
  doi = {10.1111/hae.70450}
}
Kostenlos starten →